Ji Ming Wang

Author PubWeight™ 97.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009 3.65
2 Formyl-peptide receptors revisited. Trends Immunol 2002 3.08
3 Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 2013 2.19
4 Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 2008 1.93
5 A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A 2005 1.82
6 Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2007 1.79
7 Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007 1.76
8 Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 2002 1.64
9 Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J Neuroinflammation 2010 1.41
10 Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem 2005 1.39
11 Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 2004 1.35
12 G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils. Am J Physiol Cell Physiol 2006 1.29
13 Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol 2002 1.26
14 A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. J Immunol 2010 1.26
15 Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol 2004 1.22
16 Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci U S A 2004 1.22
17 Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005 1.21
18 Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 2005 1.21
19 Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 2004 1.20
20 Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One 2013 1.18
21 Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int Immunopharmacol 2006 1.13
22 The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma. Clin Cancer Res 2005 1.12
23 Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 2007 1.10
24 Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002 1.08
25 F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. J Immunol 2007 1.08
26 Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod Pathol 2007 1.07
27 CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2. FASEB J 2005 1.06
28 CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol 2006 1.05
29 Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One 2013 1.05
30 Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem 2002 1.04
31 High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler Thromb Vasc Biol 2011 1.03
32 Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells 2012 1.01
33 Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol 2002 1.00
34 Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol Res 2005 0.99
35 Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest 2013 0.99
36 Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neurooncol 2007 0.99
37 Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes. Sci Rep 2012 0.98
38 TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J Immunol 2004 0.95
39 Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol 2003 0.95
40 The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation. Toxicol Appl Pharmacol 2008 0.95
41 The active contribution of Toll-like receptors to allergic airway inflammation. Int Immunopharmacol 2011 0.95
42 G-protein coupled chemoattractant receptors and cancer. Front Biosci 2008 0.94
43 Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand. J Immunol 2007 0.92
44 Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism. Neurobiol Dis 2011 0.90
45 Biologically active peptides interacting with the G protein-coupled formylpeptide receptor. Protein Pept Lett 2007 0.90
46 Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J 2005 0.90
47 Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J Biol Chem 2012 0.89
48 Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. Cancer Res 2012 0.89
49 Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells. J Leukoc Biol 2008 0.89
50 Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft. J Neurooncol 2008 0.89
51 Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol 2013 0.89
52 The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol 2009 0.88
53 Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. J Leukoc Biol 2002 0.88
54 Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology 2004 0.87
55 RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int Immunopharmacol 2008 0.87
56 Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression. Cancer Lett 2008 0.87
57 Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J Virol 2004 0.86
58 The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells. J Neurooncol 2007 0.86
59 Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. Carcinogenesis 2008 0.86
60 Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem 2012 0.86
61 IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases. J Immunol 2003 0.86
62 G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma. Int Immunopharmacol 2012 0.86
63 Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol 2011 0.86
64 IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J Immunol 2005 0.85
65 Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis. Immunology 2014 0.85
66 The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Virol J 2006 0.85
67 IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J Immunol 2002 0.85
68 Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites. Exp Cell Res 2007 0.84
69 Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation. J Biol Chem 2013 0.84
70 HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes. J Immunol 2011 0.83
71 Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology. J Neurooncol 2006 0.83
72 Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia. PLoS Genet 2011 0.82
73 The role of dendritic cells in neurodegenerative diseases. Arch Immunol Ther Exp (Warsz) 2002 0.82
74 Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J 2012 0.82
75 Molecular cloning and functional characterization of porcine nucleotide-binding oligomerization domain-2 (NOD2). Mol Immunol 2007 0.81
76 A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression. Cancer Lett 2012 0.81
77 Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages. Int Immunopharmacol 2007 0.80
78 Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells. J Neuroimmunol 2009 0.80
79 Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol 2005 0.80
80 Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. Neurobiol Dis 2007 0.79
81 Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells. Blood 2012 0.79
82 The immunopharmacological properties of transforming growth factor beta. Int Immunopharmacol 2005 0.79
83 Effects of cobalt chloride on nitric oxide and cytokines/chemokines production in microglia. Int Immunopharmacol 2012 0.79
84 Silencing the formylpeptide receptor FPR by short-interfering RNA. Mol Pharmacol 2004 0.79
85 Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells. Proteomics 2008 0.78
86 Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells. Int Immunopharmacol 2011 0.78
87 RNA interference as a novel and powerful tool in immunopharmacological research. Int Immunopharmacol 2007 0.78
88 Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults. Curr Med Chem 2016 0.77
89 A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors. J Neurooncol 2007 0.77
90 Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity. Int Immunopharmacol 2005 0.77
91 The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes. Cell Mol Immunol 2004 0.76
92 Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells. Inflammation 2012 0.76
93 Manipulating chemoattractant and receptor genes. In Vivo 2002 0.75
94 The role of chemokine receptors in the promotion of viral infections. Contrib Microbiol 2003 0.75
95 Silencing of ATP4B of ATPase H(+)/K(+) Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. Oncol Res 2017 0.75
96 Toll-like receptors and diseases. Int Immunopharmacol 2011 0.75
97 Chemoattractants and receptors in Alzheimer's disease. Front Biosci (Schol Ed) 2010 0.75